Meet David Lu, a research scientist at the Yale Cancer Biology Institute and co-founder of Celestra Life Science. Learn about David and his team at Celestra, where they are combining innovations in synthetic lethality and nanotechnology to develop a new class of pan-tumor therapeutic enhancers.
0 Comments